Subsense is a neurotechnology company developing the first non-surgical, nanoparticle-based bidirectional brain-computer interface. Subsense is partnered with leading global neurological research institutions.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/18/25 | $17,000,000 | Seed | ||
| 12/11/25 | $10,000,000 | Venture |
Golden Falcon Capital | undisclosed |
